A. W. Armstrong, “Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)”, Acta Derm Venereol, vol. 104, p. adv40556, Sep. 2024.